Arsenic Nanorods are elongated particles ranging from 10 to 120 nanometers (nm) with specific surface area (SSA) in the 30 - 70 m 2 /g range. Nano Arsenic is also available passivated and in Ultra high purity and high purity and coated and dispersed forms. They are also available as a nanofluid through the AE Nanofluid production group. Nanofluids are generally defined as suspended nanorods in solution either using surfactant or surface charge technology. Nanofluid dispersion and coating selection technical guidance is also available. Other nanostructures include nanoparticles, nanowhiskers, nanohorns, nanopyramids and other nanocomposites. Surface functionalized nanorods allow for the particles to be preferentially adsorbed at the surface interface using chemically bound polymers. Development research is underway in Nano Electronics and Photonics materials, such as MEMS and NEMS, Bio Nano Materials, such as Biomarkers, Bio Diagnostics & Bio Sensors, and Related Nano Materials, for use in Polymers, Textiles, Fuel Cell Layers , Composites and Solar Energy materials. Nanopowders are analyzed for chemical composition by ICP, particle size distribution (PSD) by laser diffraction, and for Specific Surface Area (SSA) by BET multi-point correlation techniques. Novel nanotechnology applications also include Quantum Dots . High surface areas can also be achieved using solutions and using thin film by sputtering targets and evaporation technology using pellets, rod and foil. Applications for Arsenic nanorods generally involve their magnetic properties and include in catalysts and magnetic recording and in medical sensors and bio medicine as a contrast enhancement agent for magnetic resonance imaging (MRI). Arsenic particles are being tested for site specific drug delivery agents for cancer therapies and in coatings, plastics, nanowire, nanofiber and textiles and in certain alloy and catalyst applications . Further research is being done for their potential electrical, dielectric, magnetic, optical, imaging, catalytic, biomedical and bioscience properties. Arsenic Nano Particles are generally immediately available in most volumes. Additional technical, research and safety (MSDS) information is available.
Arsenic is a Block P, Group 15, Period 4 element. The electronic configuration is [Ar] 3d10 4s2 4p3. In its elemental form arsenic's CAS number is 1327-53-3. The arsenic atom has a radius of 124.5.pm and it's Van der Waals radius is 185.pm. Arsenic has numerous applications as a semiconductor and other electronic applications as Indium arsenide, silicon arsenide and tin arsenidea. Arsenic is finding increasing uses as a doping agent in solid-state devices such as transistors. Gallium arsenide is used as a laser material to convert electricity directly into coherent light. Arsenic is used in bronzing and for hardening and improving the sphericity of shot. Arsenic is available as metal and compounds with purities from 99% to 99.9999% (ACS grade to ultra-high purity); metals in the form of foil, sputtering target, and rod, and compounds as submicron and nanopowder. Arsenic information, including Technical Data, Safety Data and its high purity properties, research, applications and other useful facts are discussed here. Scientific facts such as the atomic structure, ionization energy, abundance on Earth, conductivity and thermal properties are included. |
| |
Periodic table of the elements science and academic information, elements and advanced materials data, scientific presentations and all pages, designs, concepts, logos, and color schemes herein are the copyrighted proprietary rights and intellectual property of American Elements. American Elements is a U.S. Registered Trademark. © 2001-2009. American Elements. All rights reserved. |
 |
|
Recent Research & Development for Arsenic
- Arsenic accumulation in Scutellaria baicalensis Georgi and its effects on plant growth and pharmaceutical components.
Cao H, Jiang Y, Chen J, Zhang H, Huang W, Li L, Zhang W.
J Hazard Mater. 2009 Jun 16. [Epub ahead of print]
PMID: 19577841 [PubMed - as supplied by publisher]
- A comparison of arsenic tolerance, uptake and accumulation between arsenic hyperaccumulator, Pteris vittata L. and non-accumulator, P. semipinnata L.-A hydroponic study.
Lou LQ, Ye ZH, Wong MH.
J Hazard Mater. 2009 Jun 12. [Epub ahead of print]
PMID: 19577839 [PubMed - as supplied by publisher]
- Preparation and evaluation of iron-chitosan composites for removal of As(III) and As(V) from arsenic contaminated real life groundwater.
Gupta A, Chauhan VS, Sankararamakrishnan N.
Water Res. 2009 Jun 6. [Epub ahead of print]
PMID: 19577786 [PubMed - as supplied by publisher]
- Sodium arsenite-induced DAPK promoter hypermethylation and autophagy via ERK1/2 phosphorylation in human uroepithelial cells.
Huang YC, Hung WC, Chen WT, Yu HS, Chai CY.
Chem Biol Interact. 2009 Jul 2. [Epub ahead of print]
PMID: 19577553 [PubMed - as supplied by publisher]
- Carcinogenic effect of arsenate in C57BL/6J/Han mice and its modulation by different dietary selenium status.
Stepnik M, Stetkiewicz J, Krajnow A, Domeradzka K, Gradecka-Meesters D, Arkusz J, Stanczyk M, Palus J, Dziubaltowska E, Sobala W, Gromadzinska J, Wasowicz W, Rydzynski K.
Ecotoxicol Environ Saf. 2009 Jul 2. [Epub ahead of print]
PMID: 19577296 [PubMed - as supplied by publisher]
- Effects of Arsenic on Maternal and Fetal Health.
Vahter M.
Annu Rev Nutr. 2009 Jun 12. [Epub ahead of print]
PMID: 19575603 [PubMed - as supplied by publisher]
- Characterization of glutathione reductase and catalase in the fronds of two Pteris ferns upon arsenic exposure.
Kertulis-Tartar GM, Rathinasabapathi B, Ma LQ.
Plant Physiol Biochem. 2009 Jun 12. [Epub ahead of print]
PMID: 19574057 [PubMed - as supplied by publisher]
- Arsenic trioxide-induced apoptosis of Hep-2 cell line through modulating intracellular glutathione (GSH) level.
Cheng B, Yang X, An L, Gao B, Liu X.
Auris Nasus Larynx. 2009 Jun 30. [Epub ahead of print]
PMID: 19574005 [PubMed - as supplied by publisher]
- Removal of arsenic from water: Effects of competing anions on As(III) removal in KMnO(4)-Fe(II) process.
Guan X, Dong H, Ma J, Jiang L.
Water Res. 2009 Jun 11. [Epub ahead of print]
PMID: 19573891 [PubMed - as supplied by publisher]
- Increased Risk of QT Prolongation Associated with Atherosclerotic Diseases in Arseniasis Endemic Area of Southwestern Coast Taiwan.
Wang CH, Chen CL, Hsiao CK, Chiang FT, Hsu LI, Chiou HY, Hsueh YM, Wu MM, Chen CJ.
Toxicol Appl Pharmacol. 2009 Jun 29. [Epub ahead of print]
PMID: 19573547 [PubMed - as supplied by publisher]
- ARSENIC BINDING TO IRON(II) MINERALS PRODUCED BY AN IRON(III)-REDUCING AEROMONAS STRAIN ISOLATED FROM PADDY SOIL.
Wang XJ, Chen XP, Kappler A, Sun GX, Zhu YG.
Environ Toxicol Chem. 2009 Jul 2:1. [Epub ahead of print]
PMID: 19572768 [PubMed - as supplied by publisher]
- Arsenic Trioxide Inhibits Human T Cell-Lymphotropic Virus-1-Induced Syncytiums by Down-Regulating gp46.
Nabeshi H, Yoshikawa T, Kamada H, Shibata H, Sugita T, Abe Y, Nagano K, Nomura T, Minowa K, Yamashita T, Itoh N, Yoshioka Y, Tsunoda S, Tsutsumi Y.
Biol Pharm Bull. 2009 Jul;32(7):1286-8.
PMID: 19571400 [PubMed - in process]
- Arsenic accumulation by Pseudomonas stutzeri and its response to some thiol chelators.
Joshi DN, Patel JS, Flora SJ, Kalia K.
Environ Health Prev Med. 2008 Sep;13(5):257-63. Epub 2008 Jul 4.
PMID: 19568912 [PubMed - in process]
- Correlation between the arsenic concentrations in the air and the SMR of lung cancer.
Yoshikawa M, Aoki K, Ebine N, Kusunoki M, Okamoto A.
Environ Health Prev Med. 2008 Jul;13(4):207-18. Epub 2008 Apr 26.
PMID: 19568907 [PubMed - in process]
- Metallomics study using hair mineral analysis and multiple logistic regression analysis: relationship between cancer and minerals.
Yasuda H, Yoshida K, Segawa M, Tokuda R, Tsutsui T, Yasuda Y, Magara S.
Environ Health Prev Med. 2009 Jun 26. [Epub ahead of print]
PMID: 19568830 [PubMed - as supplied by publisher]
- Folate-mediated intracellular drug delivery increases the anticancer efficacy of nanoparticulate formulation of arsenic trioxide.
Chen H, Ahn R, Van den Bossche J, Thompson DH, O'Halloran TV.
Mol Cancer Ther. 2009 Jun 30. [Epub ahead of print]
PMID: 19567824 [PubMed - as supplied by publisher]
- Arsenic in contaminated waters: biogeochemical cycle, microbial metabolism and biotreatment processes.
Lièvremont D, Bertin PN, Lett MC.
Biochimie. 2009 Jun 27. [Epub ahead of print]
PMID: 19567262 [PubMed - as supplied by publisher]
- Phase II study of darinaparsin in patients with advanced hepatocellular carcinoma.
Wu J, Henderson C, Feun L, Van Veldhuizen P, Gold P, Zheng H, Ryan T, Blaszkowsky LS, Chen H, Costa M, Rosenzweig B, Nierodzik M, Hochster H, Muggia F, Abbadessa G, Lewis J, Zhu AX.
Invest New Drugs. 2009 Jun 30. [Epub ahead of print]
PMID: 19565187 [PubMed - as supplied by publisher]
- Prevalence of Kidney Dysfunction in Humans - Relationship to Cadmium Dose, Metallothionein, Immunological and Metabolic factors.
Nordberg GF, Jin T, Wu X, Lu J, Chen L, Lei L, Hong F, Nordberg M.
Biochimie. 2009 Jun 26. [Epub ahead of print]
PMID: 19563860 [PubMed - as supplied by publisher]
- [Arsenic trioxide inhibits cell growth in imatinib-resistant bcr-abl mutant cell lines in vitro]
Lu RZ, Qiu L, Wang XD, Li XF, Chen LJ, Wang XL, Zhang BL, Ma J.
Zhonghua Xue Ye Xue Za Zhi. 2009 Jan;30(1):13-7. Chinese.
PMID: 19563028 [PubMed - in process]
|
|